CrushSCI.com
Journal Selection & Manuscript Polishing Services
Frontiers in Pharmacology 临时占位封面 Medicine
Back to journal directory

Review Cycle Records

Frontiers in Pharmacology

Frontiers SCIE OA
2026 Emerging Zone 22025 CAS Zone 32025 JCR Q1
78.8Average days
63.5Median days
17Fastest days
207Longest days
4,1292025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

17 days

Bioresponsive gelatin-coated silk fibroin nanoparticles enhance roxadustat therapy in experimental pulmonary fibrosis

AuthorsElsayed A. Elmorsy; Sameh Saber; Abdulaziz A. Alsalloom; Abdullah Al-Nafeesah; Mostafa M. Khodeir; Abdullah Alolayan; Adel Alhomaidi; Mohammed Alorini; Mohamed R. Abdel-Hamed; Maha M. Amer; Huda Eltayeb; Syed Suhail Ahmed; Noura El Adle Khalaf; Eman Hamza; Ebtehal M. Abdel-Aal; Abdelrahman El-Sayed; Ahmed Y. Kira

Affiliations1. Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Saudi Arabia; 2. Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Egypt; 3. Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Egypt; 4. Department of Pathology, College of Medicine, Qassim University, Saudi Arabia; 5. Department of Pediatrics, College of Medicine, Qassim University, Saudi Arabia; 6. Department of Pathology, Faculty of Medicine, Cairo University, Egypt; 7. Department of Anatomy and Histology, College of Medicine, Qassim University, Saudi Arabia; 8. Department of Anatomy and Embryology, Faculty of Medicine, Ain Shams University, Egypt; 9. Department of Basic Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Saudi Arabia; 10. Department of Microbiology and Immunology, College of Medicine, Qassim University, Saudi Arabia; 11. Department of Biochemistry, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Saudi Arabia; 12. Department of Pathology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Saudi Arabia; 13. Faculty of Medicine, Damietta University, Egypt; 14. Department of Pharmaceutics, Faculty of Pharmacy, Delta University for Science and Technology, Egypt

Source PDF DOI Publisher page
35 days

Peedanil Gold attenuates IL-6-mediated articular pathologies in a collagen antibody-induced murine model of rheumatoid arthritis

AuthorsAcharya Balkrishna; Sonam Sharma; Aakanksha Tiwari; Sandeep Sinha; Anurag Varshney

Affiliations1. Drug Discovery and Development Division, Patanjali Research Foundation, India; 2. Department of Allied and Applied Sciences, University of Patanjali, India; 3. Patanjali United Kingdom Trust, United Kingdom

Source PDF DOI Publisher page
52 days

Hematopoietic and T-lymphopoiesis-stimulating effects of a fluorinated pyrazolopiperidine β-cyclodextrin complex in cyclophosphamide-induced hematopoietic suppression

AuthorsAssel Ten; Layilya Baktybayeva; Zhanargul Koshetova; Raushan Koizhaiganova; Guldana Daulet; Tolganay Zharkynbek; Valentina Yu

Affiliations1. Laboratory of Synthetic and Natural Medicinal Compounds Chemistry, A. B. Bekturov Institute of Chemical Sciences, Kazakhstan; 2. Department of Biophysics, Biomedicine and Neuroscience, Al Farabi Kazakh National University, Kazakhstan; 3. Department of Chemistry, Kazakh National Women’s Teacher Training University, Kazakhstan; 4. Department of Anatomy, Physiology, and Sports Medicine, Faculty of Olympic Sport, Kazakh Academy of Sport and Tourism, Kazakhstan; 5. Department of Analytical, Colloid Chemistry and Technology of Rare Elements, Farabi University, Kazakhstan

Source PDF DOI Publisher page
57 days

Physician preferences for prescribing Chinese patent medicines during pregnancy: a discrete choice experiment

AuthorsZhangyuan Yao; Yuhang Zhang; Juncheng Shu; Ting Ying; Jing Li; Yuqian Xu; Qian Zhu; Rixiang Xu; Yuanyuan Zhang; Xuefeng Xie

Affiliations1. School of Pharmacy, Anhui Medical University, China; 2. Department of Pharmacy, The Fuyang Affiliated Hospital of Anhui Medical University, China; 3. School of Humanistic Medicine, Anhui Medical University, China; 4. Key Laboratory of Public Health Social Governance, Philosophy and Social Sciences of Anhui Province, Anhui Medical University, China; 5. Anhui Provincial Drug Regulatory Scientific Research Center, Anhui Medical University, China

Source PDF DOI Publisher page
64 days

Real-world safety of terlipressin in elderly patients with liver cirrhosis and esophagogastric variceal bleeding: a focus on hyponatremia and administration methods

AuthorsYifei Peng; Jialin Li; Meng Li; Hongxia Duan; Rui Peng; Ping Zuo

Affiliations1. Leshan Hospital of Traditional Chinese Medicine, Affiliated to Chengdu University of Traditional Chinese Medicine, China

Source PDF DOI Publisher page
72 days

The orexin system as a pharmacological target in inflammation: peripheral mechanisms and safety implications

AuthorsDaniel Stránský; Michal Barabas; Martin Šíma; Ondřej Slanař

Affiliations1. Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital, Czechia; 2. Department of Anaesthesiology, Resuscitation and Intensive Medicine, First Faculty of Medicine, Charles University and General University Hospital, Czechia

Source PDF DOI Publisher page
83 days

Terminus-specific antibody development and bioanalytical assay validation to quantify active DR10624 in pharmacokinetic studies

AuthorsZhenxing Zhou; Kexin Cao; Gaofeng Yao; Yuanyuan Liu; Wenwen Duan; Chengcheng Yang; Shimei Sheng; Yanshan Huang

Affiliations1. Department of Innovative Drug Discovery and Development, Zhejiang Doer Biologics Co., Ltd., China

Source PDF DOI Publisher page
129 days

Comparative significance of piperacillin-tazobactam and cefotaxime-tazobactam in the treatment of respiratory tract infections in the elderly

AuthorsMengzhe Peng; Henian Liang; Jinwen Chen; Junli Zhang; Dongyun Qin

Affiliations1. School of Pharmacy, Guangdong Medical University, China; 2. Department of Pharmacy, Zhongshan City People’s Hospital, China

Source PDF DOI Publisher page
145 days

Computational analysis of therapeutic potential for simplified Piper spp.- derived medicinal mixtures in anxiety, sleep, pain and seizure

AuthorsB. G. Rice; B. Wooton; C. Jansen; J. Howard; J. Nixon; L. Ellis; A. Yasin; C. N. Adra; A. J. Stokes; S. A. Aporosa; A. L. Small-Howard; H. Turner

Affiliations1. Laboratory of Pharmacology and Analytics, Biology and Data Science Programs, School of Natural Sciences and Mathematics, Chaminade University, United States; 2. Graduate Program in Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, United States; 3. Laboratory of Experimental Medicine, Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii at Manoa, United States; 4. Zebrafish Toxicology, Genomics and Neurobiology Team, National Research Council of Canada, Canada; 5. GB Global Biopharma, Las Vegas, United States; 6. The Adra Institute, United States; 7. Te Huataki Waiora School of Health and Te Kura Whatu Oho Mauri School of Psychology, University of Waikato, New Zealand; 8. United Nations CIFAL Honolulu Center, Chaminade University, United States

Source PDF DOI Publisher page
174 days

Angiotensin-(1-7) in asthma and pulmonary fibrosis: mechanisms of action, clinical safety, and nano-delivery strategies

AuthorsYoussuf Khanafer; Ayman Dalol; Ahmed Z. El-Hashim; Ibrahim F. Benter; Saghir Akhtar

Affiliations1. College of Medicine, QU Health, Qatar University, Qatar; 2. Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Kuwait University, Kuwait; 3. Faculty of Pharmacy, Final International University, Cyprus

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.